Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells.

BACKGROUND The aims of this study were to ex vivo expand canine dendritic cells and determine their phenotype and functional characteristics. METHODS CD34+-selected cells and CD34+-depleted canine bone marrow (BM) cells were cultured in Iscove's modified medium for 14 days. Cytokines added to the cultures included human granylocyte/macrophage colony-stimulating factor 5 ng/ml, hFlt3 ligand 200 ng/ml, and human tumor necrosis factor-alpha 10 ng/ml. Cultured cells and purified subpopulations were assessed for cell surface antigen expression, morphology, and function by flow cytometric analysis, electron microscopy, and an allogeneic mixed lymphocyte reaction at day 14. RESULTS Two main cell populations were identified, DR++(bright)/CD14- and DR+(dim)/CD14+. Ex vivo expanded CD34+-selected cells showed increased allostimulatory activity compared to both cultured CD34+-depleted cells and mononuclear cells. In contrast, ex vivo expansion from CD34+-depleted cells was unsuccessful. After sorting cells from the ex vivo expanded CD34+-selected bone marrow to enrich for DR++/CD14- cells, a 42-fold increase (median) of allostimulatory activity was observed as compared with sorted DR+/CD14+ cells (P=0.02). CONCLUSIONS Cells with dentric cell-like phenotypes and functions can be cultured from canine CD34+-selected bone marrow cells. Future studies will address the roles of these cells in engraftment, graft versus host reactions and graft-host tolerance in a canine hematogoietic stem cell transplantaton model.

[1]  M. Shlomchik,et al.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.

[2]  V. Kindler,et al.  Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor. , 1999, Blood.

[3]  D. Sachs,et al.  Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species. , 1998, Veterinary immunology and immunopathology.

[4]  R. Storb,et al.  Characterization of monoclonal antibodies that recognize canine CD34. , 1998, Blood.

[5]  M. Hahne,et al.  Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. , 1998, Blood.

[6]  D. Hart,et al.  Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.

[7]  A. Fischer,et al.  Detection of donor‐derived Langerhans cells in MHC class II immunodeficient patients after allogeneic bone marrow transplantation , 1997, British journal of haematology.

[8]  E. Maraskovsky,et al.  Dramatic increase in the numbers of dendritic cells in the peripheral blood of healthy human volunteers treated with Flt3 ligand , 1997 .

[9]  Y. Kirita,et al.  Distribution of the dendritic cell in human organs and the incidence of GVHD. , 1997, Transplantation Proceedings.

[10]  E. Maraskovsky,et al.  Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified , 1996, The Journal of experimental medicine.

[11]  R. Storb,et al.  In vitro recall of proliferative and cytolytic responses to minor histocompatibility antigens by dendritic cell enriched canine peripheral blood mononuclear cells. , 1995, Transplantation.

[12]  D. Danilenko,et al.  Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. , 1992, Tissue antigens.

[13]  D. Danilenko,et al.  Canine leukocyte cell adhesion molecules (LeuCAMs): characterization of the CD11/CD18 family. , 1992, Tissue antigens.

[14]  W. Ladiges.  4 – Experimental Techniques Used to Study the Immune System of Dogs and Other Large Animals , 1989 .

[15]  H. Deeg,et al.  Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients. , 1988, Blood.

[16]  H. Deeg,et al.  Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs. , 1986, Blood.

[17]  R. Storb,et al.  Graft‐versus‐Host Disease in Dog and Man: The Seattle Experience , 1985, Immunological reviews.

[18]  D. Birnbaum,et al.  The importance of cross-reactions between species: mouse allo-anti-Ia monoclonal antibodies as a powerful tool to define human Ia subsets. , 1983, Human immunology.

[19]  R. Steinman,et al.  Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen , 1975, The Journal of experimental medicine.